Dextroamphetamine Saccharate — Class II drug recall D-1285-2020
Terminated recall by Teva Pharmaceuticals USA, reported 2020-06-10, distributed nationwide. Some bottles may contain mixed strengths of the product.
| Recall number | D-1285-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2020-05-22 |
| Classified | 2020-06-04 |
| Reported by FDA | 2020-06-10 |
| Terminated | 2021-05-25 |
| Distributed | Nationwide (US) |
| Quantity | 33,280 bottles |
| NDC | 00555-0775, 00555-0775-02, 00555-0776, 00555-0776-02, 00555-0777, 00555-0777-02, 00555-0971, 00555-0971-02, 00555-0972, 00555-0972-02, 00555-0973, 00555-0973-02, 00555-0974, 00555-0974-02 |
| Lot numbers | 42614718 |
| Expiration dates | 2021-02 |
Product
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0971-02
Reason for recall
Some bottles may contain mixed strengths of the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1285-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.